Abstract
On the occasion of the Spatial Statistics’ 10th Anniversary, I reflect on the past and present of Bayesian disease mapping and look into its future. I focus on some key developments of models, and on recent evolution of multivariate and adaptive Gaussian Markov random fields and their impact and importance in disease mapping. I reflect on Bayesian disease mapping as a subject of spatial statistics that has advanced to date, and continues to grow, in scope and complexity alongside increasing needs of analytic tools for contemporary health science research, such as spatial epidemiology, population and public health, and medicine. I illustrate (potential) utility and impact of some of the disease mapping models and methods for analysing and monitoring communicable disease such as the COVID-19 infection risks during an ongoing pandemic.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
